Role of monoamine transporters in mediating psychostimulant effects
Authors:
- 1 December 2005
- journal article
- research article
- Published by Springer Nature in The AAPS Journal
- Vol. 7 (4) , E847-E851
Abstract
Monoamine transporters such as the dopamine (DA) transporter (DAT) and the vesicular monoamine transporter-2 (VMAT-2) are critical regulators of DA disposition within the brain. Alterations in DA disposition can lead to conditions such as drug addiction, Parkinson’s disease, and schizophrenia, a fact that underscores the importance of understanding DAergic signaling. Psychostimulants alter DAergic signaling by influencing both DAT and VMAT-2, and although the effects of these drugs result in increased levels of synaptic DA, the mechanisms by which this occurs and the effects that these drugs exert on DAT and VMAT-2 vary. Many psychostimulants can be classified as releasers (ie, amphetamine analogs) or uptake blockers (ie, cocaine-like drugs) based on the mechanism of their acute effects on neurotransmitter flux through the DAT. Releasers and uptake blockers differentially modulate the activity and subcellular distribution of monoamine transporters, a phenomenon likely related to the neurotoxics potential of these drugs to DAergic neurons. This article will review some of the recent findings whereby releasers and uptake blockers alter DAT and VMAT-2 activity and how these alterations may be involved in neurotoxicity, thus providing insight on the neuro-degeneration observed in Parkinson’s disease.Keywords
This publication has 28 references indexed in Scilit:
- Lobeline Attenuates Methamphetamine-Induced Changes in Vesicular Monoamine Transporter 2 Immunoreactivity and Monoamine Depletions in the StriatumThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 proteinEuropean Journal of Pharmacology, 2004
- Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated MechanismJournal of Neuroscience, 2004
- Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic DeficitsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Cocaine Increases Dopamine Uptake and Cell Surface Expression of Dopamine TransportersBiochemical and Biophysical Research Communications, 2002
- Analysis of VMAT2 Binding After Methamphetamine or MPTP TreatmentJournal of Neurochemistry, 2000
- Lack of neurochemical evidence for neurotoxic effects of repeated cocaine administration in rats on brain monoamine neuronsDrug and Alcohol Dependence, 1991
- Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: A mechanism of actionNeuron, 1990
- Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neuronsBrain Research, 1990
- Cocaine Receptors on Dopamine Transporters Are Related to Self-Administration of CocaineScience, 1987